AAEP Laminitis Research Project Launched: Phase One to Investigate Pasture or Endocrinopathy-Associated Laminitis with Help of Boehringer Ingelheim Prascend® Donation

(This information is an edited press release that was originally provided by the AAEP Foundation)





On Saturday, the American Association of Equine Practitioners Foundation announced the launch of an aggressive $1 million campaign for laminitis research and the start of the first of multiple studies that will occur to help unravel the mysteries of this disease.

Also announced at the AAEP’s

Prascend® PPID (Equine Cushings Disease) Treatment Approved by FDA for US Horses

Maybe I'm biased, but I thought that the CSI (Cushings Scene Investigation) ad run by Boehringer-Ingelheim Vetmedica in British horse magazines was the most clever horse ad so far this year. It heralded the introduction of Prascend to treat Cushings-suffering horses; Prascend will soon be available in the USA.









The following press release is not an ad, it is published here as a "